Brief: Shandong Weigao Group Medical Polymer Says FY Revenue RMB 10.36 Bln

Shandong Weigao Medical Polymer

30/03/2020 10:53

March 30 (Reuters) - Shandong Weigao Group Medical Polymer
Co Ltd  1066.HK :
    * FY REVENUE RMB 10.36 BILLION VERSUS RMB8.81 BILLION
    * FY PROFIT ATTRIBUTABLE RMB1.84 BILLION VERSUS RMB1.47
BILLION
    * NO MATERIAL IMPACT ON MANUFACTURING OUTPUT AND CAPACITY
SEEN
SINCE EARLY 2020 IN MANUFACTURING SITES IN CHINA
    * SALES AND DISTRIBUTION ACTIVITIES ARE GRADUALLY REVERTING
TO
NORMAL LEVELS
    * INTERNATIONAL BUSINESS SEGMENTS CURRENTLY IMPACTED BY
DISEASE
PREVENTION & CONTROL MEASURES
    * EPIDEMIC IMPACTED OPERATIONS OF GROUP IN CERTAIN PARTS OF
CHINA

Source text for Eikon:  ID:nHKS5NcKYx 
Further company coverage:  1066.HK 

 ((Reuters.Briefs@thomsonreuters.com;))